46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
May 28, 2026
|
03:30
Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer
...
Full Story at Source
Related News
Bank of Korea Holds Rates Steady, Raises Growth Forecasts
Purito Seoul Expands Sales Through Global Multi-Channel Growth
Dow Jones Top Markets Headlines at 9 PM ET: U.S. Military Conducts New Strikes on Iran
Dow Jones Top Company Headlines at 9 PM ET: Amazon Strikes $6 Billion Deal With Snowflake for Agentic Computing Chips
